Related references
Note: Only part of the references are listed.Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters
Islam Husain et al.
JOURNAL OF ETHNOPHARMACOLOGY (2023)
Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
Wei-Wei Jia et al.
FRONTIERS IN PHARMACOLOGY (2022)
Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90α, and RXRα
Lingming Zhang et al.
PHYTOMEDICINE (2022)
The role of pregnane X receptor (PXR) in substance metabolism
Ye Lv et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Current Policies and Measures on the Development of Traditional Chinese Medicine in China
Wan-Ying Wang et al.
PHARMACOLOGICAL RESEARCH (2021)
Study on the effects of Zhuanggu Guanjie Pill, a modern Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats
Yuanyuan Chai et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Acylated iridoid glycosides with hyaluronidase inhibitory activity from the rhizomes of Picrorhiza kurroa Royle ex Benth
Toshio Morikawa et al.
PHYTOCHEMISTRY (2020)
Interpretation of Drug Interaction Using Systemic and Local Tissue Exposure Changes
Young Hee Choi
PHARMACEUTICS (2020)
Collagen synthesis-promoting and collagenase inhibitory activities of constituents isolated from the rhizomes of Picrorhiza kurroa Royle ex Benth
Toshio Morikawa et al.
FITOTERAPIA (2020)
CYP-associated drug-drug interactions: A mission accomplished?
Olavi Pelkonen et al.
ARCHIVES OF TOXICOLOGY (2020)
The beneficial pharmacological effects and potential mechanisms of picroside II: Evidence of its benefits from in vitro and in vivo
Shangying Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A Review: Effects of Macrolides on CYP450 Enzymes
Liyun Zhang et al.
CURRENT DRUG METABOLISM (2020)
Interactions of antithrombotic herbal medicines with Western cardiovascular drugs
Hua-Li Zuo et al.
PHARMACOLOGICAL RESEARCH (2020)
Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism
Feng Zhang et al.
PHYTOMEDICINE (2020)
Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway
Tingting Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Herb-Drug Interactions and Hepatotoxicity
Mohammad K. Parvez et al.
CURRENT DRUG METABOLISM (2019)
Picroside II, an iridoid glycoside from Picrorhiza kurroa, suppresses tumor migration, invasion, and angiogenesis in vitro and in vivo
Chenghua Lou et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Influences of Corydalis decumbens on the Activities of CYP450 Enzymes in Rats with a Cocktail Approach
Chen Cheng et al.
BIOMED RESEARCH INTERNATIONAL (2019)
In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
Ning Zhang et al.
PHARMACEUTICAL BIOLOGY (2019)
Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor at the Crossroads of Toxicokinetics and Toxicodynamics
Jukka Hakkola et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro
Ren-ai Xu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis
Hiteshi Dhami-Shah et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Pharmacokinetics and comparative metabolic profiling of iridoid enriched fraction of Picrorhiza kurroa - An Ayurvedic Herb
Sultan Zahiruddin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Acute Calcineurin Inhibitor Nephrotoxicity Secondary to Turmeric Intake: A Case Report
A. Nayeri et al.
TRANSPLANTATION PROCEEDINGS (2017)
In vitro - In vivo metabolism and pharmacokinetics of picroside I and II using LC-ESI-MS method
Dilawar Upadhyay et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Comprehensive Chemical Profiling of Picrorhiza kurroa Royle ex Benth Using NMR, HPTLC and LC-MS/MS Techniques
Dinesh Kumar et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2016)
Traditional Chinese medicine: potential approaches from modern dynamical complexity theories
Yan Ma et al.
FRONTIERS OF MEDICINE (2016)
Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Xiaojing Tang et al.
CURRENT DRUG METABOLISM (2015)
Pharmacokinetic Interactions Between Herbal Medicines and Prescribed Drugs: Focus on Drug Metabolic Enzymes and Transporters
Qiang Meng et al.
CURRENT DRUG METABOLISM (2015)
Picroside II Inhibits the MEK-ERK1/2-COX2 Signal Pathway to Prevent Cerebral Ischemic Injury in Rats
Tingting Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier
Petr Pavek et al.
DRUG METABOLISM REVIEWS (2014)
Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity
Min Sun et al.
FITOTERAPIA (2014)
Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs
Lin Zheng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Evaluation of Antioxidant Activity of Picrorhiza kurroa (Leaves) Extracts
K. Kant et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Chang-Xiao Liu et al.
CURRENT DRUG METABOLISM (2011)
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events A Systematic Review and Meta-analysis
Michael V. Holmes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs
Charles A. Flentge et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Beshay N. M. Zordoky et al.
CURRENT DRUG METABOLISM (2009)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Transcriptional regulation and expression of CYP3A4 in hepatocytes
Celia P. Martinez-Jimenez et al.
CURRENT DRUG METABOLISM (2007)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Cytochrome P450 (CYP) inhibition screening: Comparison of three tests
Miia Turpeinen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Clinical pharmacokinetics of atorvastatin
H Lennernas
CLINICAL PHARMACOKINETICS (2003)
CYP3A4 induction by drugs: Correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes
G Luo et al.
DRUG METABOLISM AND DISPOSITION (2002)
Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora
HF Smit et al.
JOURNAL OF ETHNOPHARMACOLOGY (2000)
Share Paper
